Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.

Show other versions (1)

Detalles Bibliográficos
Main Authors:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, Mcshane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Formato:	Journal article
Idioma:	English
Publicado:	2008

Títulos similares

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
por: Hanekom, W, et al.
Publicado: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
por: Willem A Hanekom, et al.
Publicado: (2008-07-01)

A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
por: Beveridge, N, et al.
Publicado: (2008)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
por: Dockrell, HM, et al.
Publicado: (2022)

Tuberculosis vaccines: current status and future prospects.
por: Fletcher, H, et al.
Publicado: (2006)

Local pulmonary immunological biomarkers in tuberculosis
por: Morrison, H, et al.
Publicado: (2021)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
por: Mcshane, H, et al.
Publicado: (2016)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
por: Fletcher, H, et al.
Publicado: (2009)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
por: Fletcher, H, et al.
Publicado: (2013)

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis.
por: Smith, S, et al.
Publicado: (2009)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Hazel M. Dockrell, et al.
Publicado: (2022-05-01)

Vaccines for tuberculosis
por: McShane, H
Publicado: (2013)

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development
por: Kaufmann, S, et al.
Publicado: (2017)

Tuberculosis vaccines
por: W. Hanekom
Publicado: (2014-04-01)

Vaccine strategies against tuberculosis.
por: Mcshane, H
Publicado: (2009)

Developing an improved vaccine against tuberculosis.
por: Mcshane, H
Publicado: (2004)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
por: De Cassan, S, et al.
Publicado: (2011)

Vaccine strategies against tuberculosis
por: H McShane
Publicado: (2009-03-01)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Hazel Morrison, et al.
Publicado: (2021-03-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
por: Griffiths, K, et al.
Publicado: (2011)

WHO preferred product characteristics for new vaccines against tuberculosis
por: Schrager, L, et al.
Publicado: (2018)

Tuberculosis vaccines: present and future.
por: Minassian, A, et al.
Publicado: (2008)

Tuberculosis vaccines in clinical trials.
por: Rowland, R, et al.
Publicado: (2011)

Tuberculosis vaccines: progress and challenges.
por: Checkley, A, et al.
Publicado: (2011)

Insights and challenges in tuberculosis vaccine development
por: McShane, H
Publicado: (2019)

Tuberculosis vaccines: Progress and challenges
por: Checkley, A, et al.
Publicado: (2011)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, H
Publicado: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
por: McShane, H
Publicado: (2011)

Tuberculosis vaccine promises sterilizing immunity.
por: Mcshane, H, et al.
Publicado: (2011)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa.
por: Hawkridge, T, et al.
Publicado: (2008)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
por: Stefan H. E. Kaufmann, et al.
Publicado: (2020-02-01)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
por: Mcshane, H, et al.
Publicado: (2017)

Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.
por: Dintwe, O, et al.
Publicado: (2013)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
por: Griffiths, K, et al.
Publicado: (2013)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
por: Sander, C, et al.
Publicado: (2007)

The future of vaccines for tuberculosis
por: Stockdale, L, et al.
Publicado: (2019)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
por: McShane, H
Publicado: (2023)

Clinical testing of tuberculosis vaccine candidates
por: Hatherill, M, et al.
Publicado: (2016)

Why don’t we have an effective tuberculosis vaccine yet?
por: Davenne, T, et al.
Publicado: (2016)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
por: Mcshane, H, et al.
Publicado: (2005)